Review of Biologics in Children With Rheumatic Diseases

Shabina Habibi; Athimalaipet V Ramanan


Int J Clin Rheumatol. 2012;7(1):81-93. 

In This Article


A recent case report has shown the efficacy of tocilizumab, an IL-6 inhibitor in the management of a patient with TRAPS.[76] Following treatment, an improvement in clinical features and markers of acute inflammation were observed. This cytokine may be a potential target for future therapeutic trials in TRAPS.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: